Form4insider filings, from the source

SEC Form 4 · accession 0000874015-19-000026

IONIS PHARMACEUTICALS INC · IONS

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Elizabeth L Hougen
Officer — SVP Finance & CFO
Period of report
Jan 15, 2019
Accepted (ET)
Jan 17, 2019 · 7:35 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000874015

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Jan 15, 2019M7,891$0.00A22,665D
Common StockF2Jan 15, 2019F2,842$58.26D19,823D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock UnitsF3,F4,F5—Jan 15, 2019A22,131A——Common Stock22,13122,131D
Restricted Stock UnitsF4,F5—Jan 15, 2019M7,891D——Common Stock7,89114,463D

Explanation of responses